GT Biopharma GTBP
NASDAQ GTBP
$5.46 -0.06 (-1.09%)
At close: Oct 23, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Cost of Revenue (2010 - 2013)

Updated

GT Biopharma (GTBP) posted Cost of Revenue of $57,000 for FY2014.

Analysis

GT Biopharma (GTBP) Cost of Revenue (2010 - 2013) Analysis & Trends

Since FY2010, GT Biopharma has reported Cost of Revenue for 4 years.

  • Annual Cost of Revenue shows a four-year compound annual growth rate of -3.2% (FY2010 to FY2014).
  • The FY2014 figure stands as the lowest annual Cost of Revenue since FY2011.
  • Business Quant data shows GTBP's Cost of Revenue at $94,000 in FY2012 (+95.8%), $48,000 in FY2011 (-26.2%) and $65,000 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 GT Biopharma 7.68 Mn -15.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 69,000.00
Dec 31, 2012 61,000.00
Sep 30, 2012 32,000.00
Mar 31, 2012 1,000.00
Sep 30, 2011 8,000.00
Jun 30, 2011 15,000.00
Mar 31, 2011 25,000.00
Dec 31, 2010 65,000.00
API Access

GT Biopharma Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GTBP&period=max&api_key=YOUR_API_KEY